Gilead v. Khaim — Magistrate Recommends $68 Million Judgment Against 26 HIV Drug Counterfeiters
A magistrate judge recommended a $68 million default judgment against 26 defendants who operated a large-scale scheme to flood the U.S. supply chain with counterfeit Biktarvy and Descovy HIV medications bearing Gilead’s registered trademarks.